Pioglitazone in addition to metformin improves erythrocyte deformability in patients with type 2 diabetes mellitus. Results from the PIOfix study

被引：0
|
作者：
Forst, S. [1 ]
Loebig, M. [1 ]
Lehmann, U. [2 ]
Hohberg, C. [1 ]
Friedrich, C. [1 ]
Fuchs, W. [2 ]
Pfuetzner, A. [1 ]
Forst, T. [1 ]
机构：
[1] Inst Clin Res & Dev, Mainz, Germany
[2] Takeda Pharma, Dept Med, Aachen, Germany
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1265
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Effect of pioglitazone on lipids in well controlled patients with diabetes mellitus type 2 -: Results of a pilot study
    Parhofer, KG
    Otto, C
    Geiss, HC
    Laubach, E
    Göke, B
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (01) : 49 - 52
  • [32] Hearing function in patients with Type 2 diabetes mellitus.
    Morales, VD
    Garay-Sevilla, ME
    Jáuregui-Reynaud, K
    DIABETOLOGIA, 2003, 46 : A19 - A19
  • [33] Protective role of metformin in cardiovascular mortality in patients with type 2 diabetes mellitus. 25-years prospective study
    Sosnowski, C.
    Janeczko-Sosnowska, E.
    Janeczko, D.
    Lewandowski, Z.
    Ruzyllo, W.
    EUROPEAN HEART JOURNAL, 2008, 29 : 476 - 476
  • [34] Effect of Adding Pioglitazone and/or Metformin to Insulin Treatment on Blood Pressure and Renal Function in Patients with Diabetes Mellitus Type 2-Results from the PIOCOMB-Study
    Forst, Thomas
    Hanefeld, Markolf
    Kleine, Iris
    Fuchs, Winfried
    Pfuetzner, Andreas
    DIABETES, 2011, 60 : A318 - A319
  • [35] The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus
    Erdem, Gokhan
    Dogru, Teoman
    Tasci, Ilker
    Bozoglu, Ergun
    Muhsiroglu, Ozlem
    Tapan, Serkan
    Ercin, Cemal Nuri
    Sonmez, Alper
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 (02) : 214 - 218
  • [36] Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients
    Derosa, Giuseppe
    Maffioli, Pamela
    Salvadeo, Sibilla A. T.
    Ferrari, Ilaria
    Ragonesi, Pietro D.
    Querci, Fabrizio
    Franzetti, Ivano G.
    Gadaleta, Gennaro
    Ciccarelli, Leonardina
    Piccinni, Mario N.
    D'Angelo, Angela
    Cicero, Arrigo F. G.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (06): : 887 - 895
  • [37] Long-term effects of pioglitazone and metformin on insulin sensitivity in patients with Type 2 diabetes mellitus
    Roden, M
    Laakso, M
    Johns, D
    Widel, M
    Urquhart, R
    Richardson, C
    Mariz, S
    Tan, MH
    DIABETIC MEDICINE, 2005, 22 (08) : 1101 - 1106
  • [38] Intensive control of blood glucose improves the metabolic syndrome in patients with type 2 diabetes mellitus.
    Bagg, W
    Plank, L
    Drury, PL
    Sharpe, N
    DIABETOLOGIA, 1999, 42 : A222 - A222
  • [39] Inhibitory effect of low dose pioglitazone on the development of in-stent restenosis in patients with type 2 diabetes mellitus.
    Yokoyama, J
    Kameda, K
    Yamada, M
    Tamura, Y
    Higuma, T
    Sasaki, S
    Suto, N
    Matsunaga, T
    Hanada, H
    Osanai, T
    Okumura, K
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 33A - 33A
  • [40] Valsartan in patients with arterial hypertension and type 2 diabetes mellitus.: The lapaval study
    Pérez, JCR
    Novoa, JN
    Caballero, A
    Anabitarte, A
    Plaza, C
    Palop, L
    Esparragón, FR
    NEFROLOGIA, 2005, 25 (05): : 500 - 508
12345